Emerging Strategies for Optimizing and Simplifying the Management of Resistant Hypertension
| Overview / Abstract: |
Delve into emerging therapies for resistant hypertension in this symposium highlights video. Hear from a multidisciplinary panel of experts discussing the current state of evaluation, diagnosis, and management of resistant hypertension, along with the challenges faced by clinicians. A patient case study and panel discussion provide practical advice for improving patient outcomes within the evolving treatment landscape for a robust and engaging learning experience. |
|
Expiration |
Oct 27, 2023 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
1.0 |
|
Accreditation |
ANCC, ACPE |
|
Presenters / Authors / Faculty |
Sripal Bangalore, MD, MHA; |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC |
|
Keywords / Search Terms |
ACHL Resistant hypertension, cardiology, hypertension, American Heart Association, AHA, symposium, satellite events, cardiovascular, FDA, Janssen, CME, continuing medical education, empagliflozin, dapagliflozin, canagliflozin, sacubitril, valsartan, firibastat, aprocitentan, SGLT-2 inhibitor, aminopeptidase A, dual endothelin receptor antagonist, nephrology, endocrinology, diabetes, chronic kidney disease, CKD, patient case, multidisciplinary, adherence, lifestyle modification, blood pressure, renal denervation Free CE CME |
|